CurieBio is a technology company specializing in the development of AI-driven software solutions for the life sciences industry. The company leverages machine learning to accelerate drug discovery and development, enabling researchers to predict and optimize small molecule properties, protein structures, and biological outcomes.

CurieBio

Cocoon provides employee leave management software that automates compliance, claims, and payroll processes for people teams and employees.

Cocoon

Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.

Curie.Bio

No one understands the needs of a biotech founder better than someone who just went through their own founder journey. Curie.Bio is proud to welcome Leah Sibener, Ph.D. to the CSO Partner Team as a copilot for founders. Leah co-founded and built 3T Biosciences, a therapeutics company spinout leveraging her Ph.D. work in Chris Garcia's lab at Stanford. To learn more about Leah and how she'll support founders, read her bio at the link below.

https://lnkd.in/e_kzC6XR

Join us at the 2024 Convergence Forum, where Curie.Bio CEO Zach Weinberg will be speaking alongside Steve Pagliuca (Arena Bioworks) and Daphne Zohar (PureTech Health) to discuss new models for launching therapeutics companies. 

Meeting agenda → https://lnkd.in/eqtP66Au

We're thrilled to welcome Dallas Jones to our CSO Partner Team as a copilot for the founders of our portfolio companies. Dallas provides a wealth of experience after leading multiple programs from early-stage drug discovery through clinical development in Immunology and Neuroscience through his experience at Merck and Abide Therapeutics. He also supported the launch of multiple Series A therapeutics companies at Inception Sciences, the discovery engine of Versant Ventures. To learn more about Dallas and how he'll support founders, read his bio at the link below.

https://lnkd.in/eDzkV-4q

After an illustrious career bringing 11 drugs to the clinic, we're proud to announce Darryl B. McConnell has joined Curie.Bio as a CXO in Residence to help founders of our portfolio companies create successful medicines. To learn more about Darryl and how he'll be supporting founders, read his bio at the link below.

https://lnkd.in/eFCiv99K

"Do you have a therapeutic idea worthy of funding?" Our goal is to be every founder's first phone call. Whether you reach out through a warm intro or our website, you'll get specific and candid feedback from our team. At Curie.Bio, all ideas go through the same process regardless of where they come from. Connect with us at www.curie.bio

https://lnkd.in/ee4tA35i

Metric
Company Name	CurieBio	Cocoon
Symbol
MSH ID	BIO:CURIE	COM:COCOON
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Biotechnology	Human Resources
Country	US	US
Stage
Employee Count	61	11
Website	curie.bio	cocoon.com
LinkedIn	curie-bio
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		2.82K
Web Traffic Growth		-0.17
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BIO:CURIE

CurieBio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue